Login / Signup

Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours.

Geoffrey I ShapiroRobert WesolowskiCraig DevoeSimon R LordJohn PollardBart S HendriksMartin FalkIvan Diaz-PadillaRuth PlummerTimothy Anthony Yap
Published in: British journal of cancer (2021)
NCT02157792.
Keyphrases
  • open label
  • dna damage response
  • double blind
  • placebo controlled
  • clinical trial
  • randomized controlled trial
  • dna repair